SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of report: March 15, 2004
Date of earliest event reported: March 15, 2004
BRISTOL-MYERS SQUIBB COMPANY
(Exact name of registrant as specified in its charter)
Delaware | 1-1136 | 22-079-0350 | ||
(State or other jurisdiction of incorporation) |
(Commission file number) | (IRS Employer Identification Number) |
345 Park Avenue
New York, NY 10154
(Address of principal executive office)
Registrants telephone number, including area code: (212) 546-4000
ITEM 5. OTHER EVENTS.
On March 15, 2004, Bristol-Myers Squibb Company issued a press release, a copy of which is attached as Exhibit 99.1.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(a) Financial Statements of Business to be Acquired: Not Applicable.
(b) Pro Forma Financial Information: Not Applicable.
(c) Exhibits
EXHIBIT NO. |
DESCRIPTION | |
99.1 | Press Release dated March 15, 2004 of Bristol-Myers Squibb Company. | |
99.2 | Certain supplemental information not included in the press release. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Bristol-Myers Squibb Company, | ||
By: |
/s/ SANDRA LEUNG | |
Name: |
Sandra Leung | |
Title: |
Secretary |
Date: March 15, 2004
EXHIBIT INDEX
EXHIBIT NO. |
DESCRIPTION | |
99.1 | Press Release dated March 15, 2004 of Bristol-Myers Squibb Company. | |
99.2 | Certain supplemental information not included in the press release. |